- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Earnings call: LifeMD raises 2024 revenue guidance after solid Q1 | 4 | Investing.com | ||
| Do | LifeMD Inc reports results for the quarter ended in March - Earnings Summary | 3 | Reuters | ||
| Do | Unpacking the Latest Options Trading Trends in LifeMD | 3 | Benzinga.com | ||
| Mi | LifeMD, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 02.05. | LifeMD, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.05. | LifeMD, Inc.: LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition | 1 | GlobeNewswire (USA) | ||
| 29.04. | LifeMD, Inc.: LifeMD Appoints Dr. Calum MacRae to its Board of Directors | 1 | GlobeNewswire (USA) | ||
| 24.04. | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | 1 | GlobeNewswire (USA) | ||
| 26.03. | LifeMD, Inc. 8.875% CUM PFD A declares $0.5546 dividend | 1 | Seeking Alpha | ||
| 25.03. | LifeMD, Inc.: LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 19.03. | LifeMD Shares Come Back to Life on GLP-1 Business Growth | 1 | MarketBeat | ||
| 15.03. | LifeMD, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 12.03. | LifeMD, Inc. (LFMD) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 12.03. | Earnings call: LifeMD reports growth and raises 2024 revenue guidance | 2 | Investing.com | ||
| 11.03. | LifeMD Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 11.03. | LifeMD, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 11.03. | LifeMD Non-GAAP EPS of $0.15 beats by $0.12, revenue of $44.86M beats by $4.37M | 2 | Seeking Alpha | ||
| 11.03. | Recap: LifeMD Q4 Earnings | 1 | Benzinga.com | ||
| 11.03. | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2023 Results | 238 | GlobeNewswire (Europe) | Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago... ► Artikel lesen | |
| 10.03. | LifeMD, Inc. Q4 2023 Earnings Preview | 1 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 40,680 | +1,70 % | Wall Street schiebt DAX über 18.000 Punkte. Eckert & Ziegler und Varta starten stark. | ||
| INTUITIVE SURGICAL | 359,75 | +0,21 % | Verhaltene Kauflaune bei Intuitive Surgical-Aktie (355,3540 €) | Wenig Kursbewegung gegenwärtig bei der Intuitive Surgical-Aktie . Die Aktie notiert zur Stunde bei 382,83 US-Dollar. Kaum auffällig ist aktuell am Aktienmarkt der Kurs von Intuitive Surgical. Das Wertpapier... ► Artikel lesen | |
| TELADOC HEALTH | 11,146 | +0,50 % | Teladoc Health kann Umsatz leicht steigern, Verlust aber erhöht sich | PURCHASE, New York (IT-Times) - Teladoc Health hat seine Ergebnisse für das Auftaktquartal des Geschäftsjahres 2024/2025 veröffentlicht und ein kleines Wachstum verzeichnet. Teladoc Aktie: QuartalsergebnisTeladoc... ► Artikel lesen | |
| THERMO FISHER | 550,20 | -0,09 % | Olink drops after UK antitrust regulator starts review of Thermo Fisher deal | ||
| ROKU | 53,50 | -0,52 % | Here Are 3 Reasons Why You'll Regret Not Buying Roku Stock on the Dip Right Now | ||
| DEXCOM | 119,00 | 0,00 % | Dexcom-Aktie mit leichten Kursgewinnen (120,1730 €) | Das Wertpapier von Dexcom notiert heute etwas fester. Zuletzt zahlten Investoren für die Aktie 129,49 US-Dollar. Eine Verteuerung in Höhe von 2,07 US-Dollar erfreut derzeit die Aktionäre von Dexcom.... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,390 | -0,13 % | Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results | SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,346 | -1,61 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines | ||
| DAVITA | 127,90 | +0,20 % | 6 Analysts Assess DaVita: What You Need To Know | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| PETMED EXPRESS | 4,004 | +5,59 % | PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President | Sandra Campos, retail E-commerce veteran, becomes CEO and President, effective immediately, after spending the past year serving on the Company's Board of Directors and remains on the BoardMs. Campos... ► Artikel lesen | |
| ORPEA | 13,920 | -0,11 % | ORPEA S.A.: Filing of the 2023 Universal Registration Document | Regulatory News:
ORPEA S.A. (the "Company") (Paris:ORP) filed, today, its 2023 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,239 | -4,32 % | Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 | ||
| TECAN GROUP | 337,20 | -0,71 % | Research and Markets: Europe DNA/RNA Sample Extraction and Isolation Market Analysis Report 2023-2033 Featuring F. Hoffmann-La Roche, MACHEREY-NAGEL, Merck, QIAGEN, & Tecan Group - ResearchAndMarkets.com | The "Europe DNA/RNA Sample Extraction and Isolation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe DNA/RNA sample extraction and... ► Artikel lesen | |
| QUIDELORTHO | 41,400 | +4,55 % | QuidelOrtho Reports First Quarter 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen |
LIFEMD INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 9,320 Euro und damit +0,22 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
